BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38725520)

  • 1. All-photonic kinase inhibitors: light-controlled release-and-report inhibition.
    Fleming CL; Benitez-Martin C; Bernson E; Xu Y; Kristenson L; Inghardt T; Lundbäck T; Thorén FB; Grøtli M; Andréasson J
    Chem Sci; 2024 May; 15(18):6897-6905. PubMed ID: 38725520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits.
    Ping P; Zhang J; Zheng YT; Li RC; Dawn B; Tang XL; Takano H; Balafanova Z; Bolli R
    Circ Res; 1999 Sep; 85(6):542-50. PubMed ID: 10488057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
    Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
    J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
    Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
    Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.
    Elkamhawy A; Ali EMH; Lee K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1574-1602. PubMed ID: 34233563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human tyrosine kinase, Lck, in yeast Saccharomyces cerevisiae: growth suppression and strategy for inhibitor screening.
    Koyama M; Saito S; Nakagawa R; Katsuyama I; Hatanaka M; Yamamoto T; Arakawa T; Tokunag M
    Protein Pept Lett; 2006; 13(9):915-20. PubMed ID: 17100647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell.
    Torigoe T; Millan JA; Chan KW; Taichman R; Brian AA; Reed JC; Tachman R [corrected to Taichman R]
    J Exp Med; 1994 Sep; 180(3):1115-27. PubMed ID: 7914906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes.
    Kabouridis PS; Magee AI; Ley SC
    EMBO J; 1997 Aug; 16(16):4983-98. PubMed ID: 9305640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
    Cochrane R; Clark RB; Huang CK; Cone RE
    J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the gamma-herpesvirus agents of malignant catarrhal fever.
    Swa S; Wright H; Thomson J; Reid H; Haig D
    Immunology; 2001 Jan; 102(1):44-52. PubMed ID: 11168636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
    Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
    Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.
    Vahedi S; Chueh FY; Chandran B; Yu CL
    BMC Cancer; 2015 Jul; 15():551. PubMed ID: 26210498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Lck is critically required for sphingosine-induced conformational activation of Bak and mitochondrial cell death.
    Kim MJ; Park MT; Yoon CH; Byun JY; Lee SJ
    Biochem Biophys Res Commun; 2008 May; 370(2):353-8. PubMed ID: 18371298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
    Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
    J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lymphocyte kinase Lck and phosphatidylinositol 3-kinase by a novel immunosuppressant, lymphostin.
    Nagata H; Yano H; Sasaki K; Sato S; Nakanishi S; Takahashi I; Tamaoki T
    Biosci Biotechnol Biochem; 2002 Mar; 66(3):501-7. PubMed ID: 12005041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.